• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化:衰老、线粒体功能障碍与细胞生物能量学

Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics.

作者信息

Zank Daniel C, Bueno Marta, Mora Ana L, Rojas Mauricio

机构信息

Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

出版信息

Front Med (Lausanne). 2018 Feb 5;5:10. doi: 10.3389/fmed.2018.00010. eCollection 2018.

DOI:10.3389/fmed.2018.00010
PMID:29459894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5807592/
Abstract

At present, the etiology of idiopathic pulmonary fibrosis (IPF) remains elusive. Over the past two decades, however, researchers have identified and described the underlying processes that result in metabolic dysregulation, metabolic reprogramming, and mitochondrial dysfunction observed in the cells of IPF lungs. Metabolic changes and mitochondrial dysfunction in IPF include decreased efficiency of electron transport chain function with increasing production of reactive oxygen species, decreased mitochondrial biogenesis, and impaired mitochondrial macroautophagy, a key pathway for the removal of dysfunctional mitochondria. Metabolic changes in IPF have potential impact on lung cell function, differentiation, and activation of fibrotic responses. These alterations result in activation of TGF-β and predispose to the development of pulmonary fibrosis. IPF is a disease of the aged, and many of these same bioenergetic changes are present to a lesser extent with normal aging, raising the possibility that these anticipated alterations in metabolic processes play important roles in creating susceptibility to the development of IPF. This review explores what is known regarding the cellular metabolic and mitochondrial changes that are found in IPF, and examines this body of literature to identify future research direction and potential points of intervention in the pathogenesis of IPF.

摘要

目前,特发性肺纤维化(IPF)的病因仍不清楚。然而,在过去二十年中,研究人员已经识别并描述了导致IPF肺细胞中代谢失调、代谢重编程和线粒体功能障碍的潜在过程。IPF中的代谢变化和线粒体功能障碍包括电子传递链功能效率降低,活性氧生成增加,线粒体生物合成减少,以及线粒体巨自噬受损,线粒体巨自噬是清除功能失调线粒体的关键途径。IPF中的代谢变化对肺细胞功能、分化和纤维化反应的激活具有潜在影响。这些改变导致转化生长因子-β(TGF-β)激活,并易引发肺纤维化。IPF是一种老年疾病,许多相同的生物能量变化在正常衰老过程中也会在较小程度上出现,这增加了这些预期的代谢过程改变在导致IPF易感性方面发挥重要作用的可能性。本综述探讨了关于IPF中发现的细胞代谢和线粒体变化的已知情况,并审视了这一系列文献,以确定未来的研究方向以及IPF发病机制中的潜在干预点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819e/5807592/f4ccf2a97edd/fmed-05-00010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819e/5807592/575feaf8128c/fmed-05-00010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819e/5807592/f4ccf2a97edd/fmed-05-00010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819e/5807592/575feaf8128c/fmed-05-00010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819e/5807592/f4ccf2a97edd/fmed-05-00010-g002.jpg

相似文献

1
Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics.特发性肺纤维化:衰老、线粒体功能障碍与细胞生物能量学
Front Med (Lausanne). 2018 Feb 5;5:10. doi: 10.3389/fmed.2018.00010. eCollection 2018.
2
PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses.PINK1-PARK2介导的线粒体自噬在慢性阻塞性肺疾病和特发性肺纤维化发病机制中的作用
Inflamm Regen. 2018 Oct 24;38:18. doi: 10.1186/s41232-018-0077-6. eCollection 2018.
3
Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者骨髓间充质干细胞的衰老。
Stem Cell Res Ther. 2018 Sep 26;9(1):257. doi: 10.1186/s13287-018-0970-6.
4
Mitochondrial Quality Control in Age-Related Pulmonary Fibrosis.衰老相关肺纤维化中线粒体质量控制。
Int J Mol Sci. 2020 Jan 18;21(2):643. doi: 10.3390/ijms21020643.
5
Fibroblast Senescence in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中的成纤维细胞衰老
Front Cell Dev Biol. 2020 Nov 25;8:593283. doi: 10.3389/fcell.2020.593283. eCollection 2020.
6
Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis.线粒体功能障碍和代谢重编程作为特发性肺纤维化的驱动因素。
Redox Biol. 2020 Jun;33:101509. doi: 10.1016/j.redox.2020.101509. Epub 2020 Mar 19.
7
Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis.揭示特发性肺纤维化中重要细胞器应激与氧化应激之间的相互作用。
Biochim Biophys Acta Mol Cell Res. 2024 Mar;1871(3):119676. doi: 10.1016/j.bbamcr.2024.119676. Epub 2024 Jan 17.
8
Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.吡非尼酮可抑制自噬不足时肌成纤维细胞分化和肺纤维化的发展。
Respir Res. 2017 Jun 2;18(1):114. doi: 10.1186/s12931-017-0600-3.
9
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.肺成纤维细胞、衰老与特发性肺纤维化
Ann Am Thorac Soc. 2016 Dec;13 Suppl 5:S417-S421. doi: 10.1513/AnnalsATS.201605-341AW.
10
Mitochondrial Dysfunction in Lung Resident Mesenchymal Stem Cells from Idiopathic Pulmonary Fibrosis Patients.特发性肺纤维化患者肺固有间充质干细胞中线粒体功能障碍。
Cells. 2023 Aug 17;12(16):2084. doi: 10.3390/cells12162084.

引用本文的文献

1
A Simple Ratio in a Complex Disease: Exploring the Neutrophil-to-Lymphocyte Ratio in Idiopathic Pulmonary Fibrosis.复杂疾病中的一个简单比率:探索特发性肺纤维化中的中性粒细胞与淋巴细胞比率。
J Clin Med. 2025 Jul 18;14(14):5100. doi: 10.3390/jcm14145100.
2
Current Understanding of Pulmonary Fibrosis: Pathogenesis, Diagnosis, and Therapeutic Approaches.肺纤维化的当前认识:发病机制、诊断及治疗方法
Can Respir J. 2025 Jul 15;2025:3183241. doi: 10.1155/carj/3183241. eCollection 2025.
3
Aging-associated interleukin-11 drives the molecular mechanism and targeted therapy of idiopathic pulmonary fibrosis.

本文引用的文献

1
ATF3 represses PINK1 gene transcription in lung epithelial cells to control mitochondrial homeostasis.转录激活因子 3 通过抑制肺上皮细胞中 PINK1 基因的转录来控制线粒体稳态。
Aging Cell. 2018 Apr;17(2). doi: 10.1111/acel.12720. Epub 2018 Jan 24.
2
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function.甲状腺激素通过改善上皮细胞线粒体功能抑制小鼠肺纤维化。
Nat Med. 2018 Jan;24(1):39-49. doi: 10.1038/nm.4447. Epub 2017 Dec 4.
3
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
衰老相关的白细胞介素-11驱动特发性肺纤维化的分子机制及靶向治疗
Eur J Med Res. 2025 Jul 2;30(1):542. doi: 10.1186/s40001-025-02755-5.
4
The potential role of biomarkers CD28 and PF4 in the pathogenesis of idiopathic pulmonary fibrosis and their impact on the prognosis: an immune microenvironment analysis.生物标志物CD28和PF4在特发性肺纤维化发病机制中的潜在作用及其对预后的影响:免疫微环境分析
Hereditas. 2025 Jun 7;162(1):98. doi: 10.1186/s41065-025-00464-x.
5
Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition in pulmonary fibrosis pathogenesis.肺泡上皮细胞功能障碍与上皮-间质转化在肺纤维化发病机制中的作用
Front Mol Biosci. 2025 Apr 24;12:1564176. doi: 10.3389/fmolb.2025.1564176. eCollection 2025.
6
SS-31: A promising therapeutic agent against bleomycin-induced pulmonary fibrosis in Mice.SS-31:一种有望治疗博来霉素诱导的小鼠肺纤维化的治疗剂。
PLoS One. 2025 Apr 29;20(4):e0315473. doi: 10.1371/journal.pone.0315473. eCollection 2025.
7
PGC-1α mediates migrasome secretion accelerating macrophage-myofibroblast transition and contributing to sepsis-associated pulmonary fibrosis.过氧化物酶体增殖物激活受体γ共激活因子1α(PGC-1α)介导迁移体分泌,加速巨噬细胞向肌成纤维细胞转变,促进脓毒症相关的肺纤维化。
Exp Mol Med. 2025 Apr;57(4):759-774. doi: 10.1038/s12276-025-01426-z. Epub 2025 Apr 1.
8
Decreased Complex I Activity in Blood lymphocytes Correlates with Idiopathic Pulmonary Fibrosis Severity.血液淋巴细胞中复合物I活性降低与特发性肺纤维化严重程度相关。
Biochem Genet. 2025 Mar 4. doi: 10.1007/s10528-025-11071-w.
9
Melittin alleviates bleomycin-induced pulmonary fibrosis through regulating TGF-β1/Smad2/3 and AMPK/SIRT1/PGC-1α signaling pathways.蜂毒肽通过调节TGF-β1/Smad2/3和AMPK/SIRT1/PGC-1α信号通路减轻博来霉素诱导的肺纤维化。
Iran J Basic Med Sci. 2025;28(4):426-433. doi: 10.22038/ijbms.2024.81986.17740.
10
Mitochondrial and tRNA Gene Variants Associated with Risk and Prognosis of Idiopathic Pulmonary Fibrosis.与特发性肺纤维化风险和预后相关的线粒体及转运RNA基因变异
Int J Mol Sci. 2025 Feb 6;26(3):1378. doi: 10.3390/ijms26031378.
特发性肺纤维化的新兴疗法,一种与年龄相关的进行性疾病。
Nat Rev Drug Discov. 2017 Nov;16(11):755-772. doi: 10.1038/nrd.2017.170. Epub 2017 Oct 6.
4
Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study.特发性肺纤维化的代谢异质性:一项代谢组学研究。
BMJ Open Respir Res. 2017 Jun 5;4(1):e000183. doi: 10.1136/bmjresp-2017-000183. eCollection 2017.
5
IPF lung fibroblasts have a senescent phenotype.特发性肺纤维化肺成纤维细胞具有衰老表型。
Am J Physiol Lung Cell Mol Physiol. 2017 Dec 1;313(6):L1164-L1173. doi: 10.1152/ajplung.00220.2017. Epub 2017 Aug 31.
6
Metabolic characterization and RNA profiling reveal glycolytic dependence of profibrotic phenotype of alveolar macrophages in lung fibrosis.代谢特征分析和RNA谱分析揭示了肺纤维化中肺泡巨噬细胞促纤维化表型对糖酵解的依赖性。
Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L834-L844. doi: 10.1152/ajplung.00235.2017. Epub 2017 Aug 10.
7
Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis.细胞外线粒体DNA由成纤维细胞产生并可预测特发性肺纤维化患者的死亡情况。
Am J Respir Crit Care Med. 2017 Dec 15;196(12):1571-1581. doi: 10.1164/rccm.201612-2480OC.
8
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis .衰老细胞清除药物靶向作用于肺泡上皮细胞功能,从而减轻实验性肺纤维化。
Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.02367-2016. Print 2017 Aug.
9
A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.心脏重塑发生与进展的分子机制综述
Oxid Med Cell Longev. 2017;2017:3920195. doi: 10.1155/2017/3920195. Epub 2017 Jul 2.
10
HMGB1 promotes HLF-1 proliferation and ECM production through activating HIF1-α-regulated aerobic glycolysis.高迁移率族蛋白B1(HMGB1)通过激活低氧诱导因子1α(HIF1-α)调控的有氧糖酵解促进人肺成纤维细胞-1(HLF-1)增殖和细胞外基质(ECM)生成。
Pulm Pharmacol Ther. 2017 Aug;45:136-141. doi: 10.1016/j.pupt.2017.05.015. Epub 2017 May 30.